| Literature DB >> 35333152 |
Anatte Margalit1, David Sheehan1, James C Carolan1, Kevin Kavanagh.
Abstract
The fungal pathogen Aspergillus fumigatus is frequently cultured from the sputum of cystic fibrosis (CF) patients along with the bacterium Pseudomonas aeruginosa. A. fumigatus secretes a range of secondary metabolites, and one of these, gliotoxin, has inhibitory effects on the host immune response. The effect of P. aeruginosa culture filtrate (CuF) on fungal growth and gliotoxin production was investigated. Exposure of A. fumigatus hyphae to P. aeruginosa cells induced increased production of gliotoxin and a decrease in fungal growth. In contrast, exposure of A. fumigatus hyphae to P. aeruginosa CuF led to increased growth and decreased gliotoxin production. Quantitative proteomic analysis was used to characterize the proteomic response of A. fumigatus upon exposure to P. aeruginosa CuF. Changes in the profile of proteins involved in secondary metabolite biosynthesis (e.g. gliotoxin, fumagillin, pseurotin A), and changes to the abundance of proteins involved in oxidative stress (e.g. formate dehydrogenase) and detoxification (e.g. thioredoxin reductase) were observed, indicating that the bacterial secretome had a profound effect on the fungal proteome. Alterations in the abundance of proteins involved in detoxification and oxidative stress highlight the ability of A. fumigatus to differentially regulate protein synthesis in response to environmental stresses imposed by competitors such as P. aeruginosa. Such responses may ultimately have serious detrimental effects on the host.Entities:
Keywords: Aspergillus; Pseudomonas; gliotoxin; infection; proteomics
Mesh:
Substances:
Year: 2022 PMID: 35333152 PMCID: PMC9558348 DOI: 10.1099/mic.0.001164
Source DB: PubMed Journal: Microbiology (Reading) ISSN: 1350-0872 Impact factor: 2.956
Fig. 1.The effect of cells on A. fumigatus hyphal growth and gliotoxin production. (a) A. fumigatus hyphae (wet weight mg ml−1) after co-incubation for 24 h with nutrient broth (control, 1 ml) or cell suspension (OD600 0.1, 0.5, 1.0; 1 ml). (b) Gliotoxin (µg mg−1 hyphae) produced by A. fumigatus in Czapek-Dox liquid media supplemented with nutrient broth (control, 1 ml) or cell suspension (OD600 0.1, 0.5, 1.0; 1 ml) measured by RP-HPLC. ***P<0.001, **P<0.01, *P<0.05, ns: non-significant.
Fig. 2.The effect of CuF on early stages of A. fumigatus growth and gliotoxin production. A. fumigatus germinating conidia grown in Czapek-Dox media for 4 h prior to exposure to non-supplemented media (sterile Czapek-Dox), A. fumigatus CuF or CuF for 24 h. Fungal growth was measured as wet weight (mg ml−1). Gliotoxin (µg ml−1) was extracted from fungal cultures after 24 h and measured by RP-HPLC ***P<0.001, **P<0.01.
Fig. 3.(a) PCA of A. fumigatus protein groups. PCA of A. fumigatus exposed to A. fumigatus CuF (blue) and CuF (orange). A clear distinction can be observed between each of the groups exposed to CuF and A. fumigatus CuF. (b) Differential abundance of proteins in the A. fumigatus proteome. Volcano plots derived from pairwise comparisons between A. fumigatus cultured in CuF and A. fumigatus CuF. The distribution of quantified proteins according to P value (−log10 P-value) and fold change (log2 mean LFQ intensity difference) is shown. Proteins above the line are considered statistically significant (P<0.05). The top 10 statistically significant proteins that increased in abundance are highlighted in red. The top 10 statistically significant proteins that decreased in abundance are highlighted in blue. The gene names are included beside each protein.
Relative fold differences of the top 20 SSDA (t-test, P<0.05) proteins detected in the proteomic dataset arising from A. fumigatus groups exposed to A. fumigatus CuF and CuF
|
Gene |
Protein name |
Fold change |
|---|---|---|
|
hhtA AFUA_1G17440 (psoC) ftmOx1 AFUA_5G03540 AFUA_2G15290 NRPS14 AFUA_7G04490 AFUA_6G04920 AFUA_8G00440 (psoF) |
Histone H3 Methyltransferase psoC Verruculogen synthase Thioredoxin reductase, putative DUF636 domain protein Non-ribosomal peptide synthetase 14 Ribosomal protein S28e Formate dehydrogenase Dual-functional monooxygenase/methyltransferase psoF |
+53.81 +49.55 +44.10 +43.91 +37.79 +24.69 +18.90 +18.64 +18.35 |
|
(AFUA_6G09740) gliT AFUA_1G17440 AFUA_6G09730 (gliF) AFUA_6G09720 (gliN) AFUA_2G11120 AFUA_6G09690 (gliG) AFUA_6G12780 crf2 AFUA_5G09680 AFUA_6G09745 AFUA_5G01880 |
Thioredoxin reductase gliT ABC multidrug transporter A-1 Cytochrome P450 monooxygenase gliF
Uncharacterized protein Glutathione Uncharacterized protein Probable glycosidase crf2 Succinate dehydrogenase cytochrome b560 subunit Uncharacterized protein Uncharacterized protein |
−53.23 −34.45 −28.47 −21.13 −14.49 −12.55 −10.58 −10.34 −8.45 −7.26 −6.75 |
Changes in the abundance of proteins associated with secondary metabolite biosynthesis: relative fold differences of SSDA (t-test, P<0.05) proteins associated with secondary metabolite biosynthesis between A. fumigatus groups exposed to A. fumigatus CuF and CuF
|
Gene |
Protein name |
Fold change |
|---|---|---|
|
AFUA_1G17440 (psoC) |
Methyltransferase psoC |
+49.55 |
|
ftmOx1 |
Verruculogen synthase |
+44.10 |
|
NRPS14 |
PKS-NRPS hybrid synthetase psoA |
+24.69 |
|
AFUA_8G00440 (psoF) |
Methyltransferase psoF |
+18.35 |
|
ftmMT |
6-Hydroxytryprostatin B |
+11.45 |
|
af390-400 |
|
+7.18 |
|
(AFUA_8G00580) psoE |
Glutathione |
+5.37 |
|
af380 |
Polyketide transferase af380 |
+4.24 |
|
ftmPT1 |
Tryprostatin B synthase |
+3.69 |
|
AFUA_5G04080 |
Terpene cyclase |
+1.54 |
|
(AFUA_6G09740) gliT |
Thioredoxin reductase gliT |
−53.23 |
|
(AFUA_6G09730) gliF |
Cytochrome P450 monooxygenase gliF |
−28.47 |
|
(AFUA_6G09720) gliN |
|
−21.13 |
|
(AFUA_6G09690) gliG |
Glutathione |
−12.55 |
Changes to the A. fumigatus stress response pathway: relative fold differences of SSDA (t-test, P<0.05) proteins associated with a general stress response and mitochondria-related oxidative stress between A. fumigatus groups exposed to CuF and A. fumigatus CuF
|
Gene |
Protein |
Fold change |
|---|---|---|
|
AFUA_5G03540 |
Thioredoxin reductase |
+43.91 |
|
AFUA_6G04920 |
Formate dehydrogenase |
+18.64 |
|
AFUA_3G14540 |
Heat shock protein Hsp30/Hsp42 |
+6.67 |
|
AFUA_5G09330 |
CipC-like antibiotic response protein, putative |
+6.08 |
|
AFUA_8G06080 |
Nitric oxide dioxygenase |
+3.75 |
|
katG |
Catalase-peroxidase |
+3.64 |
|
AFUA_3G12560 |
Allantoicase Alc |
+3.27 |
|
AFUA_1G08880 |
Iron/copper transporter Atx1 |
+3.22 |
|
AFUA_4G03120 |
Mitochondrial cytochrome b2, putative |
+2.93 |
|
AFUA_4G11250 |
Carbonic anhydrase |
+2.27 |
|
AFUA_7G02070 |
AIF-like mitochondrial oxidoreductase |
+2.25 |
|
AFUA_2G05060 |
Alternative oxidase |
+1.95 |
|
Pmp20 |
Putative peroxiredoxin pmp20 |
+1.89 |
|
AFUA_4G03900 |
Peroxisomal multifunctional beta-oxidation protein |
+1.83 |
|
Atg8 |
Autophagy-related protein 8 |
+1.80 |
|
AFUA_1G11180 |
Heat shock protein/chaperonin HSP78, putative |
+1.56 |
|
svf1 |
Survival factor 1 |
+1.54 |
|
AFUA_5G09680 |
Succinate dehydrogenase cytochrome b560 subunit |
−8.45 |
|
AFUA_4G11390 |
Ubiquinol-cytochrome |
−5.85 |
|
AFUA_2G13110 |
Cytochrome |
−1.94 |
|
AFUA_4G06790 |
Cytochrome |
−1.83 |
|
AFUA_3G06190 |
Cytochrome |
−1.54 |
|
AFUA_2G11750 |
Mitochondrial DnaJ chaperone (Mdj1), putative |
−1.51 |